Ameriprise’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.27M Sell
76,625
-15,150
-17% -$448K ﹤0.01% 2866
2025
Q1
$2.74M Buy
91,775
+1,148
+1% +$34.3K ﹤0.01% 2706
2024
Q4
$2.6M Sell
90,627
-75,390
-45% -$2.16M ﹤0.01% 2764
2024
Q3
$6.41M Buy
166,017
+60,026
+57% +$2.32M ﹤0.01% 2195
2024
Q2
$3.41M Buy
105,991
+8,305
+9% +$267K ﹤0.01% 2576
2024
Q1
$3.79M Sell
97,686
-3,655
-4% -$142K ﹤0.01% 2533
2023
Q4
$3.12M Sell
101,341
-14,834
-13% -$457K ﹤0.01% 2643
2023
Q3
$2.6M Sell
116,175
-10,506
-8% -$235K ﹤0.01% 2695
2023
Q2
$2.72M Sell
126,681
-4,431
-3% -$95.2K ﹤0.01% 2724
2023
Q1
$3.15M Sell
131,112
-3,861
-3% -$92.6K ﹤0.01% 2613
2022
Q4
$3.13M Sell
134,973
-28,007
-17% -$650K ﹤0.01% 2579
2022
Q3
$2.61M Sell
162,980
-101,395
-38% -$1.62M ﹤0.01% 2657
2022
Q2
$4.68M Sell
264,375
-26,389
-9% -$468K ﹤0.01% 2330
2022
Q1
$5.92M Buy
290,764
+21,878
+8% +$446K ﹤0.01% 2311
2021
Q4
$5.02M Buy
268,886
+119,132
+80% +$2.23M ﹤0.01% 2458
2021
Q3
$2.96M Sell
149,754
-11,575
-7% -$228K ﹤0.01% 2704
2021
Q2
$3.81M Sell
161,329
-24,522
-13% -$580K ﹤0.01% 2632
2021
Q1
$4.41M Buy
185,851
+118,044
+174% +$2.8M ﹤0.01% 2468
2020
Q4
$1.36M Sell
67,807
-22,725
-25% -$455K ﹤0.01% 2944
2020
Q3
$1.89M Buy
90,532
+2,881
+3% +$60K ﹤0.01% 2697
2020
Q2
$1.53M Buy
87,651
+1,383
+2% +$24.2K ﹤0.01% 2731
2020
Q1
$1.41M Sell
86,268
-6,545
-7% -$107K ﹤0.01% 2660
2019
Q4
$1.91M Buy
92,813
+1,660
+2% +$34.2K ﹤0.01% 2755
2019
Q3
$1.05M Sell
91,153
-18,715
-17% -$215K ﹤0.01% 3001
2019
Q2
$1.45M Buy
+109,868
New +$1.45M ﹤0.01% 2909
2018
Q3
Sell
-8,830
Closed -$211K 3725
2018
Q2
$211K Sell
8,830
-46,282
-84% -$1.11M ﹤0.01% 3464
2018
Q1
$1.41M Buy
+55,112
New +$1.41M ﹤0.01% 2823
2016
Q2
Sell
-75,865
Closed -$1.38M 3765
2016
Q1
$1.38M Buy
+75,865
New +$1.38M ﹤0.01% 2701